These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 30065205)

  • 1. Tubeimoside I Protects Dopaminergic Neurons Against Inflammation-Mediated Damage in Lipopolysaccharide (LPS)-Evoked Model of Parkinson's Disease in Rats.
    He D; Huang B; Fu S; Li Y; Ran X; Liu Y; Chen G; Liu J; Liu D
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30065205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
    Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vanillin Protects Dopaminergic Neurons against Inflammation-Mediated Cell Death by Inhibiting ERK1/2, P38 and the NF-κB Signaling Pathway.
    Yan X; Liu DF; Zhang XY; Liu D; Xu SY; Chen GX; Huang BX; Ren WZ; Wang W; Fu SP; Liu JX
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peiminine Protects Dopaminergic Neurons from Inflammation-Induced Cell Death by Inhibiting the ERK1/2 and NF-κB Signalling Pathways.
    Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Liu D; Fu S
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson's Disease Models.
    Huang B; Liu J; Ju C; Yang D; Chen G; Xu S; Zeng Y; Yan X; Wang W; Liu D; Fu S
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polydatin Prevents Lipopolysaccharide (LPS)-Induced Parkinson's Disease via Regulation of the AKT/GSK3β-Nrf2/NF-κB Signaling Axis.
    Huang B; Liu J; Meng T; Li Y; He D; Ran X; Chen G; Guo W; Kan X; Fu S; Wang W; Liu D
    Front Immunol; 2018; 9():2527. PubMed ID: 30455692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways.
    Li Y; Zeng Y; Meng T; Gao X; Huang B; He D; Ran X; Du J; Zhang Y; Fu S; Hu G
    Int Immunopharmacol; 2019 Oct; 75():105739. PubMed ID: 31351366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models.
    Tai W; Ye X; Bao X; Zhao B; Wang X; Zhang D
    Neuropharmacology; 2013 Dec; 75():201-12. PubMed ID: 23916477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erinacine A Prevents Lipopolysaccharide-Mediated Glial Cell Activation to Protect Dopaminergic Neurons against Inflammatory Factor-Induced Cell Death In Vitro and In Vivo.
    Lee SL; Hsu JY; Chen TC; Huang CC; Wu TY; Chin TY
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054997
    [No Abstract]   [Full Text] [Related]  

  • 11. Activation of Nur77 in microglia attenuates proinflammatory mediators production and protects dopaminergic neurons from inflammation-induced cell death.
    Liu TY; Yang XY; Zheng LT; Wang GH; Zhen XC
    J Neurochem; 2017 Feb; 140(4):589-604. PubMed ID: 27889907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nilotinib inhibits microglia-mediated neuroinflammation to protect against dopaminergic neuronal death in Parkinson's disease models.
    Wu J; Xu X; Zheng L; Mo J; Jin X; Bao Y
    Int Immunopharmacol; 2021 Oct; 99():108025. PubMed ID: 34364303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-survival and anti-inflammatory roles of NF-κB c-Rel in the Parkinson's disease models.
    Wang Z; Dong H; Wang J; Huang Y; Zhang X; Tang Y; Li Q; Liu Z; Ma Y; Tong J; Huang L; Fei J; Yu M; Wang J; Huang F
    Redox Biol; 2020 Feb; 30():101427. PubMed ID: 31986466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease.
    Yao L; Zhu Z; Wu J; Zhang Y; Zhang H; Sun X; Qian C; Wang B; Xie L; Zhang S; Lu G
    FASEB J; 2019 Jul; 33(7):8648-8665. PubMed ID: 30995872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Sonic hedgehog signal by Purmorphamine, in a mouse model of Parkinson's disease, protects dopaminergic neurons and attenuates inflammatory response by mediating PI3K/AKt signaling pathway.
    Shao S; Wang GL; Raymond C; Deng XH; Zhu XL; Wang D; Hong LP
    Mol Med Rep; 2017 Aug; 16(2):1269-1277. PubMed ID: 28627590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson's disease models are mediated by GPR109A-dependent mechanisms.
    Fu SP; Wang JF; Xue WJ; Liu HM; Liu BR; Zeng YL; Li SN; Huang BX; Lv QK; Wang W; Liu JX
    J Neuroinflammation; 2015 Jan; 12():9. PubMed ID: 25595674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson's disease mouse model.
    Yang C; Mo Y; Xu E; Wen H; Wei R; Li S; Zheng J; Li W; Le B; Chen Y; Pan H; Huang S; Wang S; Wang Q
    Int Immunopharmacol; 2019 Oct; 75():105651. PubMed ID: 31401385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alkaloids from piper longum protect dopaminergic neurons against inflammation-mediated damage induced by intranigral injection of lipopolysaccharide.
    He H; Guo WW; Xu RR; Chen XQ; Zhang N; Wu X; Wang XM
    BMC Complement Altern Med; 2016 Oct; 16(1):412. PubMed ID: 27776556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urate inhibits microglia activation to protect neurons in an LPS-induced model of Parkinson's disease.
    Bao LH; Zhang YN; Zhang JN; Gu L; Yang HM; Huang YY; Xia N; Zhang H
    J Neuroinflammation; 2018 May; 15(1):131. PubMed ID: 29720230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolvin D2 recovers neural injury by suppressing inflammatory mediators expression in lipopolysaccharide-induced Parkinson's disease rat model.
    Tian Y; Zhang Y; Zhang R; Qiao S; Fan J
    Biochem Biophys Res Commun; 2015 May; 460(3):799-805. PubMed ID: 25824039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.